Syntenin-1-mediated arthritogenicity is advanced by reprogramming RA metabolic macrophages and Th1 cells. Meyer A, Sienes RE, Nijim W, Zanotti B, et al. Ann Rheum Dis 2023;82:483-495.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Meyer A, Sienes RE, Nijim W, Zanotti B, et al. Syntenin-1-mediated arthritogenicity is advanced by reprogramming RA metabolic macrophages and Th1 cells. Ann Rheum Dis 2023;82:483-495.
PMID: 36593091